(Q51812672)
Statements
A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder. (English)
1 reference
Jean-Pierre Lindenmayer
1 reference
Anzalee Khan
1 reference
Sashank Kaushik
1 reference
Saurabh Kaushik
1 reference
1 April 2011
1 reference
31
1 reference
2
1 reference
160-168
1 reference